Titmarsh Drew M, Glass Nick R, Mills Richard J, Hidalgo Alejandro, Wolvetang Ernst J, Porrello Enzo R, Hudson James E, Cooper-White Justin J
Australian Institute for Bioengineering &Nanotechnology, The University of Queensland, St. Lucia, QLD 4072, Australia.
School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia.
Sci Rep. 2016 Apr 21;6:24637. doi: 10.1038/srep24637.
Inducing cardiomyocyte proliferation in post-mitotic adult heart tissue is attracting significant attention as a therapeutic strategy to regenerate the heart after injury. Model animal screens have identified several candidate signalling pathways, however, it remains unclear as to what extent these pathways can be exploited, either individually or in combination, in the human system. The advent of human cardiac cells from directed differentiation of human pluripotent stem cells (hPSCs) now provides the ability to interrogate human cardiac biology in vitro, but it remains difficult with existing culture formats to simply and rapidly elucidate signalling pathway penetrance and interplay. To facilitate high-throughput combinatorial screening of candidate biologicals or factors driving relevant molecular pathways, we developed a high-density microbioreactor array (HDMA)--a microfluidic cell culture array containing 8100 culture chambers. We used HDMAs to combinatorially screen Wnt, Hedgehog, IGF and FGF pathway agonists. The Wnt activator CHIR99021 was identified as the most potent molecular inducer of human cardiomyocyte proliferation, inducing cell cycle activity marked by Ki67, and an increase in cardiomyocyte numbers compared to controls. The combination of human cardiomyocytes with the HDMA provides a versatile and rapid tool for stratifying combinations of factors for heart regeneration.
在有丝分裂后的成年心脏组织中诱导心肌细胞增殖作为损伤后心脏再生的一种治疗策略正引起广泛关注。模式动物筛选已确定了几种候选信号通路,然而,目前尚不清楚这些通路在人类系统中单独或联合应用时能在多大程度上得到利用。从人类多能干细胞(hPSC)定向分化而来的人类心脏细胞的出现,现在提供了在体外研究人类心脏生物学的能力,但以现有的培养形式,简单快速地阐明信号通路的渗透和相互作用仍然很困难。为了便于对驱动相关分子通路的候选生物制剂或因子进行高通量组合筛选,我们开发了一种高密度微生物反应器阵列(HDMA)——一种包含8100个培养室的微流控细胞培养阵列。我们使用HDMA对Wnt、Hedgehog、IGF和FGF通路激动剂进行组合筛选。Wnt激活剂CHIR99021被确定为人类心肌细胞增殖最有效的分子诱导剂,与对照组相比,它可诱导以Ki67为标志的细胞周期活性,并增加心肌细胞数量。人类心肌细胞与HDMA的结合为分层筛选心脏再生因子组合提供了一种通用且快速的工具。